Work

GPER blockers as Nox downregulators: A new drug class to target chronic non-communicable diseases

Year: 2017

Type: review

Source: The Journal of Steroid Biochemistry and Molecular Biology

DOI: 10.1016/j.jsbmb.2017.03.019

Authors: Matthias R. Meyer, Matthias Barton

Institutions: University of Zurich, Triemli Hospital

Language: English

Topic: Estrogen and related hormone effects

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Awards: Role of Estrogen Receptor GPER for Toll-Like Receptor 4-Dependent Inflammatory Activation in Atherosclerosis, Molecular mechanisms of obesity-associated cardiovascular injury, Pathomechanisms of cardiovascular injury in obesity, Role of G Protein-Coupled Estrogen Receptor for Endothelial Function and Vascular Inflammation in Early Atherosclerosis

OpenAlex ID: W2602396445

FWCI: 0.282

Cites: 67

Cited by: 26

Related to: 10